Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04417621
Title Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
Recruitment Recruiting
Gender
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

melanoma

Therapies

LTT462 + LXH 254

Trametinib

Ribociclib

Age Groups: senior | child | adult
Covered Countries USA

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute Recruiting Los Angeles California 90025 United States Details
University of California Los Angeles Recruiting Los Angeles California 90095 United States Details
UCSF Medical Center Recruiting San Francisco California 94143 United States Details
Florida Cancer Specialists Sarasota Office Recruiting Fort Myers Florida 33901 United States Details
University of Miami Recruiting Miami Florida 33136 United States Details
H Lee Moffitt Cancer Center and Research Institute Moffitt McKinley Outpatient Ct Recruiting Tampa Florida 33612 United States Details
Massachusetts General Hospital Massachusetts General Hospital Recruiting Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Dept.of DFCI Recruiting Boston Massachusetts 02215 United States Details
Mayo Clinic Mayo Rochester Recruiting Rochester Minnesota 55905 United States Details
NYU Laura and Isaac Perlmutter Cancer Center Recruiting New York New York 10016 United States Details
Memorial Sloan Kettering Dept. of MSKCC Recruiting New York New York 10017 United States Details
University of Pittsburgh Medical Center Recruiting Pittsburgh Pennsylvania 15213 United States Details
University of TX MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Novartis Investigative Site Recruiting North Sydney New South Wales 2060 Australia Details
Novartis Investigative Site Recruiting Wooloongabba Queensland 4102 Australia Details
Novartis Investigative Site Recruiting Subiaco Western Australia 6008 Australia Details
Novartis Investigative Site Recruiting Salzburg 5020 Austria Details
Novartis Investigative Site Recruiting Leuven 3000 Belgium Details
Novartis Investigative Site Recruiting Wilrijk 2610 Belgium Details
Novartis Investigative Site Recruiting Lille Cedex 59037 France Details
Novartis Investigative Site Recruiting Marseille Cedex 9 13913 France Details
Novartis Investigative Site Recruiting Paris Cedex 10 75475 France Details
Novartis Investigative Site Recruiting Pierre Benite Cedex 69495 France Details
Novartis Investigative Site Recruiting Toulouse Cedex 9 31059 France Details
Novartis Investigative Site Recruiting Villejuif Cedex 94800 France Details
Novartis Investigative Site Recruiting Dresden 01307 Germany Details
Novartis Investigative Site Recruiting Essen 45147 Germany Details
Novartis Investigative Site Recruiting Ramat Gan 52621 Israel Details
Novartis Investigative Site Recruiting Maastricht 6229 HX Netherlands Details
Novartis Investigative Site Recruiting Oslo 0379 Norway Details
Novartis Investigative Site Recruiting Lausanne 1011 Switzerland Details
Novartis Investigative Site Recruiting Zuerich 8091 Switzerland Details
Novartis Investigative Site Recruiting Manchester M20 2BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field